Opioids

The FDA warned patients and prescribers about the risk of potential dental problems arising from the use of buprenorphine medicines to treat opioid addiction and pain. The agency said the opioid addiction treatment had been reported to cause tooth decay, infection, and, in some cases,...

A jury in Suffolk County State Supreme Court found Teva Pharmaceutical Industries Ltd (NYSE: TEVA) contributed to New York's opioid epidemic. Next, the court will hold another trial to determine how much Teva should pay. "Teva Pharmaceuticals USA and others misled the...

Jurors in Cleveland federal court have determined that pharmacy chain operators CVS Health Corp (NYSE: CVS), Walgreens Boots Alliance Inc (NASDAQ: WBA), and Walmart Inc (NYSE: WMT) helped fuel the opioid epidemic in two counties in Ohio, Reuters reports. The...

Oklahoma’s Supreme Court struck down a 2019 ruling against Johnson & Johnson (NYSE: JNJ) and overturned a $465 million fine, finding a judge incorrectly interpreted public nuisance laws. The 5-to-1 decision that overturned the $465 million verdict issued by Cleveland...

Four large pharmacy chains, including Walgreens Boots Alliance Inc (NYSE: WBA), CVS Health Corp (NYSE: CVS), Walmart Inc (NYSE: WMT), and Giant Eagle Inc, will face their first trial over the U.S. opioid epidemic, Reuters reported. The Ohio counties of...

Cardinal Health Inc (NYSE: CAH), McKesson Corporation (NYSE: MCK), and AmerisourceBergen Corp (NYSE: ABC), accused of U.S. addiction crisis, have struck a settlement with a tribal government, Reuters reports. As part of the deal with Cherokee Nation's...

Endo International plc (NASDAQ: ENDP) has agreed to pay $50 million to resolve lawsuits by New York state and two of its largest counties related to the sale and marketing of opioids. Endo said the settlement includes no admission of wrongdoing by Endo or its subsidiaries. The...

Shares of Endo International (NASDAQ: ENDP) came in crashing after The Wall Street Journal reported that the drugmaker had engaged Alvarez & Marsal to look into a potential financial restructuring. The report of a potential restructuring is only the latest of woes Endo...

Heron Therapeutics Inc (NASDAQ: HRTX) has announced the online publication of a new analysis from the Phase 3 EPOCH 1 and EPOCH 2 studies evaluating Zynrelef (bupivacaine and meloxicam) in adults aged 65 years and older after bunionectomy and hernia repair. Zynrelef is an extended-...

McKesson Corporation (NYSE: MCK), Cardinal Health Inc (NYSE: CAH), and AmerisourceBergen Corp (NYSE: ABC) have agreed to pay up to $1.179 billion to settle claims by New York state and two of its biggest counties over their role in the U.S. opioid epidemic. The...

U.S. states attorneys general are expected to conclude the $26B settlement with three drug distributors and Johnson & Johnson (NYSE: JNJ) this week over several opioid-crisis lawsuits against them. What Happened: Drug distributors McKesson Corporation (...

Opiant Pharmaceuticals Inc (NASDAQ: OPNT) announced top-line results from its confirmatory pharmacokinetic study for OPNT003, nasal nalmefene, for opioid overdose.  The 68-subject study compared 3mg nalmefene nasal spray with 1 mg intramuscular nalmefene injection. ...

Teva Pharmaceutical Industries Ltd (NYSE: TEVA), Endo International Plc (NASDAQ: ENDP), and AbbVie Inc's (NYSE: ABBV) Allergan misleadingly marketed opioid drugs as having a low addiction risk, a lawyer for a New York county told jurors, urging them to...

On Saturday, Johnson & Johnson (NYSE: JNJ) said it would end the manufacture and sale of opioids nationwide in a $230 million settlement with the New York state, Reuters reports.  J&J will not face the jury trial scheduled to begin on Tuesday on Long Island with...

Trevena Inc (NASDAQ: TRVN) has announced that the National Institute on Drug Abuse (NIDA), part of the NIH, has resumed recruitment for its proof-of-concept study for TRV734. The Company has collaborated with NIDA to evaluate TRV734 as potential maintenance therapy for opioid use...